Athira Pharma, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Athira Pharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q3 2024.
Athira Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.94M, a 17.7% increase year-over-year.
Athira Pharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $11M, a 2.72% increase year-over-year.
Athira Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $10.6M, a 0.16% increase from 2022.
Athira Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.6M, a 129% increase from 2021.
Athira Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.62M, a 630% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$11M	$2.94M	+$442K	+17.7%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$10.6M	$3.21M	+$86K	+2.76%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-01
Q1 2024	$10.5M	$2.68M	-$103K	-3.7%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$10.6M	$2.23M	-$132K	-5.59%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-22
Q3 2023	$10.8M	$2.49M	+$74K	+3.06%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-07
Q2 2023	$10.7M	$3.12M	+$24K	+0.78%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-01
Q1 2023	$10.7M	$2.78M	+$51K	+1.87%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-15
Q4 2022	$10.6M	$2.36M	+$925K	+64.5%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-22
Q3 2022	$9.68M	$2.42M	+$1.32M	+119%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	$8.37M	$3.1M	+$1.99M	+179%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	$6.38M	$2.73M	+$1.76M	+180%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	$4.62M	$1.44M	+$1.02M	+246%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-23
Q3 2021	$3.6M	$1.11M	+$994K	+895%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-10
Q2 2021	$2.61M	$1.11M	+$1.06M	+2163%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-15
Q1 2021	$1.55M	$974K	+$916K	+1579%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	$633K	$415K			Oct 1, 2020	Dec 31, 2020	10-K	2022-03-28
Q3 2020		$111K	+$42K	+60.9%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020		$49K			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-16
Q1 2020		$58K			Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-13
Q3 2019		$69K			Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.